OPKO HEALTH, INC. (OPK) — SEC Financial Statements & Analysis

OPKO HEALTH, INC. (OPK) is a pharmaceutical preparations company, incorporated in DE. OPKO HEALTH, INC. trades on Nasdaq as: OPK. OPKO HEALTH, INC. (OPK)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-27. Based on that filing, OPKO HEALTH, INC. carries a market cap of $1.13B, a P/E ratio of -15.54x, a P/B ratio of 0.96x, a P/S ratio of 1.93x, an enterprise value of $1.22B, and an EV/EBITDA multiple of 29.48x. On profitability, it posts a gross margin of 40.77%, an operating margin of -8.21%, a net margin of -12.40%, a Return on Equity (ROE) of -5.88%, a Return on Assets (ROA) of -3.83%, and a Return on Invested Capital (ROIC) of -3.32%. Per share, it reports EPS of $-0.10, diluted EPS of $-0.10, free cash flow per share of $-0.18, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -11.47% year-over-year, net income growth of -58.85% year-over-year, and EPS growth of -57.07% year-over-year. On the balance sheet, it maintains a current ratio of 3.35x, a quick ratio of 2.56x, working capital of $350.87M, a debt-to-equity ratio of 0.54x, a debt ratio of 0.35, an interest coverage ratio of -1.07x, free cash flow of $-134.02M (TTM), and net debt of $89.86M. Figures sourced from SEC EDGAR.

Market Cap

$1.13B

P/E TTM

-15.54x

EPS TTM

$-0.10

P/B TTM

0.96x

ROE TTM

-5.88%

ROA TTM

-3.83%

Debt To Equity

0.54x

Free Cash Flow TTM

$-134.02M

Net Revenue TTM Growth 1Y

-11.47%

Data as of 2026-06-30 · Source: SEC EDGAR